Therapeutic potential of the Proprotein Convertase Subtilisin/Kexin family in vascular disease.
Suur BE, Chemaly M, Lindquist Liljeqvist M, Djordjevic D, Stenemo M, Bergman O, Karlöf E, Lengquist M, Odeberg J, Hurt-Camejo E, Eriksson P, Ketelhuth DFJ, Roy J, Hedin U, Nyberg M, Matic L.
Suur BE, et al. Among authors: roy j.
Front Pharmacol. 2022 Sep 15;13:988561. doi: 10.3389/fphar.2022.988561. eCollection 2022.
Front Pharmacol. 2022.
PMID: 36188622
Free PMC article.